Navega Therapeutics, Inc., 2026-01-30
An SEC Form D private-offering notice from San Diego, CA, a $2,500,000 filer-stated offering target in Biotech. Filed 2026-01-30. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Preclinical biotech developing non-opioid gene therapies for chronic pain using zinc finger and CRISPR based epigenome regulation
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Critical Loop, Inc., 2026-02-02, $37.4M, Long Beach, CA
- Compvide Inc., 2026-02-03, $3M, Renton, WA
- Zocks Communications, Inc., 2026-02-02, $46.5M, San Francisco, CA
- PridCor Therapeutics, LLC, 2026-02-02, $1M, Tuscaloosa, AL
- Sophia Space, Inc., 2026-02-02, $13.6M, Pasadena, CA
- Imagine Devices Inc., 2026-01-30, $200K, Austin, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.